CAL101 shows promising results and is set to enter phase 2 development
Category: News
The company’s workforce will volunteer and fundraise for Team Jak throughout the year
Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK
The five new programmes are designed to fit alongside full-time work and clinical practice
The two-year programme will use virtual reality technology to teach essential skills
The London hub is home to life sciences companies including Novartis, Engitix and invoX Pharma
There are around 55,100 new prostate cancer cases in the UK every year
Study reveals potential new strategy for managing inflammatory bowel disease
Partnership to harness AI for DUB-focused preclinical programmes
Acquisition to enhance Lundbeck’s neuroscience pipeline